Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Aug-17 9:40 PM View:  | Payne John Bernard Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 6,195 | $6.72 | $41,630.40 | (100%) 6.2K to 0 | 0% |
| 02-Aug-17 9:27 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 1,500 | $6.72 | $10,080.00 | (100%) 1.5K to 0 | 0% |
| 02-Aug-17 3:59 PM View: | Fried Richard B 10% Owner | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition (change in control) | 2,648,700 | $6.72 | $17,799,200.00 | (33%) 7.95M to 5.3M | 0% |
| 02-Aug-17 9:36 PM View: | Lismore Damian T. Chief Financial Officer | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 67,750 | $6.72 | $455,280.00 | (63%) 107.71K to 39.96K | 0% |
| 02-Aug-17 9:22 PM View: | Farrell Geraldine T VP Operations, General Counsel | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 18,980 | $6.72 | $127,546.00 | (36%) 52.16K to 33.18K | 0% |
| 02-Aug-17 9:18 PM View: | Brown Christopher Nigel Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 8,800 | $6.72 | $59,136.00 | (100%) 8.8K to 0 | 0% |
| 02-Aug-17 9:38 PM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 16,400 | $6.72 | $110,208.00 | (100%) 16.4K to 0 | 0% |
| 02-Aug-17 9:30 PM View: | Heffernan Mark Chief Executive Officer | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 109,810 | $6.72 | $737,923.00 | (31%) 353.4K to 243.59K | 0% |
| 02-Aug-17 9:25 PM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 42,600 | $6.72 | $286,272.00 | (100%) 42.6K to 0 | 0% |
| 02-Aug-17 3:54 PM View: | Farallon Capital Management... 10% Owner | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition (change in control) | 2,648,700 | $6.72 | $17,799,200.00 | (33%) 7.95M to 5.3M | 0% |
| 02-Aug-17 3:59 PM View: | Fried Richard B 10% Owner | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition (change in control) Duplicate | 5,297,390 | $6.72 | $35,598,500.00 | (100%) 5.3M to 0 | 0% |
| 02-Aug-17 9:34 PM View: | Kilty Cormac G Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 155,164 | $6.72 | $1,042,700.00 | (100%) 155.16K to 0 | 0% |
| 02-Aug-17 9:36 PM View: | Lismore Damian T. Chief Financial Officer | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 39,963 | $6.72 | $268,551.00 | (100%) 39.96K to 0 | 0% |
| 02-Aug-17 9:22 PM View: | Farrell Geraldine T VP Operations, General Counsel | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 33,180 | $6.72 | $222,970.00 | (100%) 33.18K to 0 | 0% |
| 02-Aug-17 9:32 PM View: | Horn Jurgen Chief Product Development Ofcr | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 15,750 | $6.72 | $105,840.00 | (100%) 15.75K to 0 | 0% |
| 02-Aug-17 9:30 PM View: | Heffernan Mark Chief Executive Officer | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 243,587 | $6.72 | $1,636,900.00 | (100%) 243.59K to 0 | 0% |
| 02-Aug-17 9:40 PM View: | Payne John Bernard Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 10,800 | $6.72 | $72,576.00 | (64%) 17.0K to 6.2K | 0% |
| 02-Aug-17 3:54 PM View: | Farallon Capital Management... 10% Owner | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition (change in control) | 5,297,390 | $6.72 | $35,598,500.00 | (100%) 5.3M to 0 | 0% |
| 02-Aug-17 9:27 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 16,020 | $6.72 | $107,654.00 | (91%) 17.52K to 1.5K | 0% |
| 02-Aug-17 4:09 PM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 13,580 | $6.72 | $91,257.60 | (100%) 13.58K to 0 | 0% |
| 02-Aug-17 9:18 PM View: | Brown Christopher Nigel Director | Nexvet Biopharma Plc (NVET) | 31-Jul-17 | Disposition | 7,200 | $6.72 | $48,384.00 | (45%) 16.0K to 8.8K | 0% |
| 05-Jul-17 12:11 PM View: | Heffernan Mark Chief Executive Officer | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 60,643 | $0.12 | $7,580.38 | 21% 292.75K to 353.4K | |
| 05-Jul-17 12:22 PM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 9% 39.0K to 42.6K | |
| 05-Jul-17 12:18 PM View: | Lismore Damian T. Chief Financial Officer | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 34,000 | $0.12 | $4,250.00 | 51% 66.63K to 100.63K | |
| 05-Jul-17 12:28 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 26% 13.92K to 17.52K | |
| 05-Jul-17 12:59 PM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 28% 12.8K to 16.4K | |
| 05-Jul-17 1:56 PM View: | Payne John Bernard Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 27% 13.39K to 17.0K | |
| 05-Jul-17 1:51 PM View: | Kilty Cormac G Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 2% 151.56K to 155.16K | |
| 05-Jul-17 12:18 PM View: | Lismore Damian T. Chief Financial Officer | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 7,079 | $0.12 | $884.88 | 7% 100.63K to 107.71K | |
| 05-Jul-17 1:30 PM View: | Farrell Geraldine T VP Operations, General Counsel | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 12,340 | $0.12 | $1,542.50 | 21% 57.75K to 70.09K | |
| 05-Jul-17 5:49 PM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | < 1% 2.66M to 2.66M | |
| 05-Jul-17 1:20 PM View: | Brown Christopher Nigel Director | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 3,600 | $0.12 | $450.00 | 29% 12.4K to 16.0K | |
| 05-Jul-17 1:30 PM View: | Farrell Geraldine T VP Operations, General Counsel | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 9,060 | $0.12 | $1,132.50 | 13% 70.09K to 79.15K | |
| 05-Jul-17 1:39 PM View: | Horn Jurgen Chief Product Development Ofcr | Nexvet Biopharma Plc (NVET) | 01-Jul-17 | Option Exercise | 15,750 | $0.12 | $1,968.75 | 100% 0 to 15.75K | |
| 05-Jul-17 12:59 PM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 30-Jun-17 | Option Exercise | 500 | $0.12 | $62.50 | 4% 12.3K to 12.8K | |
| 05-Jul-17 5:49 PM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 30-Jun-17 | Option Exercise | 500 | $0.12 | $62.50 | < 1% 2.66M to 2.66M | |
| 05-Jul-17 12:22 PM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 30-Jun-17 | Option Exercise | 500 | $0.12 | $62.50 | 1% 38.5K to 39.0K | |
| 05-Jul-17 12:28 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 30-Jun-17 | Option Exercise | 500 | $0.12 | $62.50 | 4% 13.42K to 13.92K | |
| 03-Apr-17 2:03 PM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 31-Mar-17 | Option Exercise | 500 | $0.12 | $62.50 | < 1% 2.66M to 2.66M | |
| 04-Apr-17 11:16 AM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 31-Mar-17 | Option Exercise | 500 | $0.12 | $62.50 | 1% 38.0K to 38.5K | |
| 04-Apr-17 11:20 AM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 31-Mar-17 | Option Exercise | 500 | $0.12 | $62.50 | 4% 12.92K to 13.42K | |
| 04-Apr-17 11:23 AM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 31-Mar-17 | Option Exercise | 500 | $0.12 | $62.50 | 4% 11.8K to 12.3K | |
| 03-Jan-17 7:29 PM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 31-Dec-16 | Option Exercise | 500 | $0.12 | $62.50 | 1% 37.5K to 38.0K | |
| 03-Jan-17 7:34 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 31-Dec-16 | Option Exercise | 500 | $0.12 | $62.50 | 4% 12.42K to 12.92K | |
| 03-Jan-17 7:38 PM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 31-Dec-16 | Option Exercise | 500 | $0.12 | $62.50 | 4% 11.3K to 11.8K | |
| 04-Jan-17 10:57 AM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 31-Dec-16 | Option Exercise | 500 | $0.12 | $62.50 | < 1% 2.66M to 2.66M | |
| 04-Oct-16 9:26 AM View: | Patel Rajiv A Director | Nexvet Biopharma Plc (NVET) | 30-Sep-16 | Option Exercise | 500 | $0.12 | $62.50 | < 1% 2.66M to 2.66M | |
| 04-Oct-16 3:44 PM View: | Gunn George W Director | Nexvet Biopharma Plc (NVET) | 30-Sep-16 | Option Exercise | 500 | $0.12 | $62.50 | 1% 37.0K to 37.5K | |
| 04-Oct-16 3:47 PM View: | Hanna Ashraf Director | Nexvet Biopharma Plc (NVET) | 30-Sep-16 | Option Exercise | 500 | $0.12 | $62.50 | 4% 11.92K to 12.42K | |
| 04-Oct-16 3:52 PM View: | McCracken Joseph S Director | Nexvet Biopharma Plc (NVET) | 30-Sep-16 | Option Exercise | 500 | $0.12 | $62.50 | 5% 10.8K to 11.3K |
